OrganoClick Dividende

Zukünftiges Wachstum Kriterienprüfungen 0/6

OrganoClick hat in der Vergangenheit keine Dividende gezahlt.

Wichtige Informationen

n/a

Dividendenausschüttung

n/a

Ausschüttungsquote

Durchschnittlicher Branchenertrag	2.5%
Nächster Dividendenzahlungstermin	n/a
Ex-Dividendendatum	n/a
Dividende pro Aktie	n/a
Gewinn pro Aktie	-SEK 0.17
Prognose der Dividendenrendite	n/a

Aktuelle Dividendenentwicklung

Keine Aktualisierungen

Recent updates

A Piece Of The Puzzle Missing From OrganoClick AB (publ)'s (STO:ORGC) 26% Share Price Climb

Jun 19

Shareholders May Find It Hard To Justify Increasing OrganoClick AB (publ)'s (STO:ORGC) CEO Compensation For Now

May 09

Earnings Release: Here's Why Analysts Cut Their OrganoClick AB (publ) (STO:ORGC) Price Target To kr3.00

May 03

Sentiment Still Eluding OrganoClick AB (publ) (STO:ORGC)

Mar 25

Earnings Update: OrganoClick AB (publ) (STO:ORGC) Just Reported And Analysts Are Trimming Their Forecasts

Feb 18

OrganoClick (STO:ORGC) Seems To Use Debt Quite Sensibly

Jan 09

Is OrganoClick AB (publ) (STO:ORGC) Potentially Undervalued?

May 11

There's No Escaping OrganoClick AB (publ)'s (STO:ORGC) Muted Revenues Despite A 33% Share Price Rise

Apr 18

Here's Why OrganoClick (STO:ORGC) Can Afford Some Debt

Jan 25

Does OrganoClick (STO:ORGC) Have A Healthy Balance Sheet?

Sep 21

OrganoClick AB (publ) (STO:ORGC) Just Reported Earnings, And Analysts Cut Their Target Price

Feb 21

Health Check: How Prudently Does OrganoClick (STO:ORGC) Use Debt?

Feb 20

Is OrganoClick (STO:ORGC) Weighed On By Its Debt Load?

Apr 20

Loss-Making OrganoClick AB (publ) (STO:ORGC) Expected To Breakeven In The Medium-Term

Mar 23

Should You Take Comfort From Insider Transactions At OrganoClick AB (publ) (STO:ORGC)?

Feb 12

Stabilität und Wachstum des Zahlungsverkehrs

Rufe Dividendendaten ab

Stabile Dividende: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Dividende je Aktie von ORGC in der Vergangenheit stabil war.

Wachsende Dividende: Unzureichende Daten, um festzustellen, ob die Dividendenzahlungen von ORGC gestiegen sind.

Dividendenrendite im Vergleich zum Markt

OrganoClick Dividendenrendite im Vergleich zum Markt

Wie sieht die Dividendenrendite von ORGC im Vergleich zum Markt aus?
Segment	Dividendenrendite
Unternehmen (ORGC)	n/a
Untere 25 % des Marktes (SE)	1.5%
Markt Top 25 % (SE)	4.3%
Branchendurchschnitt (Chemicals)	2.5%
Analystenprognose (ORGC) (bis zu 3 Jahre)	n/a

Bemerkenswerte Dividende: Es ist nicht möglich, die Dividendenrendite von ORGC im Vergleich zu den unteren 25 % der Dividendenzahler zu bewerten, da das Unternehmen keine aktuellen Ausschüttungen gemeldet hat.

Hohe Dividende: Es ist nicht möglich, die Dividendenrendite von ORGC im Vergleich zu den besten 25 % der Dividendenzahler zu bewerten, da das Unternehmen keine aktuellen Ausschüttungen gemeldet hat.

Gewinnausschüttung an die Aktionäre

Abdeckung der Erträge: Unzureichende Daten zur Berechnung der Ausschüttungsquote von ORGC, um festzustellen, ob die Dividendenzahlungen durch die Gewinne gedeckt sind.

Barausschüttung an die Aktionäre

Cashflow-Deckung: Es ist nicht möglich, die Nachhaltigkeit der Dividende zu berechnen, da ORGC keine Ausschüttungen gemeldet hat.

OrganoClick Dividende

Zukünftiges Wachstum Kriterienprüfungen 0/6

Wichtige Informationen

Aktuelle Dividendenentwicklung

Recent updates

Forecast to breakeven in 2025

Second quarter 2024 earnings released: kr0.029 loss per share (vs kr0.027 loss in 2Q 2023)

Consensus EPS estimates fall by 17%

A Piece Of The Puzzle Missing From OrganoClick AB (publ)'s (STO:ORGC) 26% Share Price Climb

OrganoClick AB (publ) Announces CFO Changes

OrganoClick AB (publ) Approves Board Changes

Shareholders May Find It Hard To Justify Increasing OrganoClick AB (publ)'s (STO:ORGC) CEO Compensation For Now

Earnings Release: Here's Why Analysts Cut Their OrganoClick AB (publ) (STO:ORGC) Price Target To kr3.00

First quarter 2024 earnings: EPS in line with expectations, revenues disappoint

Consensus EPS estimates upgraded to kr0.06 loss, revenue downgraded

New major risk - Revenue and earnings growth

OrganoWood AB (publ) Announces Three-Year Results from the Field Study EN 12037 for Organowood Nowa

Jessica Sundborg to Leave as CFO of OrganoClick AB (publ)

New major risk - Revenue and earnings growth

Organoclick AB (Publ) Announces That Malin Bugge, Board Member, Has Declined Re-Election

Full year 2023 earnings: EPS and revenues miss analyst expectations

Sentiment Still Eluding OrganoClick AB (publ) (STO:ORGC)

OrganoClick and PulPac Launches Plastic-Free Coffee Lid Reducing Co2 Footprint with 80%

Consensus EPS estimates fall by 13%

Earnings Update: OrganoClick AB (publ) (STO:ORGC) Just Reported And Analysts Are Trimming Their Forecasts

Full year 2023 earnings: EPS and revenues miss analyst expectations

New minor risk - Share price stability

Consensus EPS estimates upgraded to kr0.14 loss

OrganoClick (STO:ORGC) Seems To Use Debt Quite Sensibly

OrganoClick AB (publ), Annual General Meeting, May 15, 2024

OrganoClick AB (publ) to Report Fiscal Year 2024 Results on Feb 13, 2025

Co-founder & CEO recently bought kr202k worth of stock

New minor risk - Share price stability

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

New major risk - Revenue and earnings growth

New major risk - Revenue and earnings growth

Forecast to breakeven in 2025

OrganoClick AB (publ) Announces Nomination Committee

Chairman recently bought kr147k worth of stock

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

New minor risk - Profitability

Consensus EPS estimates fall by 25%

Organoclick Launches Biobased and Eco-Labelled Textile Waterproofing

Organoclick AB (Publ) Announces Board Changes

Consensus estimates of losses per share improve by 25%

Is OrganoClick AB (publ) (STO:ORGC) Potentially Undervalued?

There's No Escaping OrganoClick AB (publ)'s (STO:ORGC) Muted Revenues Despite A 33% Share Price Rise

Full year 2022 earnings: EPS and revenues miss analyst expectations

Chairman recently bought kr206k worth of stock

Environmental & Sustainability Director recently bought kr120k worth of stock

Environmental & Sustainability Director recently bought kr120k worth of stock

Consensus revenue estimates fall by 11%

Full year 2022 earnings: EPS and revenues miss analyst expectations

Forecast breakeven date pushed back to 2025

Here's Why OrganoClick (STO:ORGC) Can Afford Some Debt

Chief Financial Officer recently bought kr58k worth of stock

OrganoClick AB (publ) to Report Q1, 2023 Results on May 05, 2023

Director recently bought kr54k worth of stock

No independent directors

Consensus EPS estimates fall by 14%

Forecast breakeven date pushed back to 2024

Does OrganoClick (STO:ORGC) Have A Healthy Balance Sheet?

Consensus EPS estimates fall by 32%

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates fall by 36%

First quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Consensus EPS estimates fall by 36%

No independent directors

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

OrganoClick AB Appoints Mattias Bodin as New Environmental and Sustainability Director

Co-founder & CEO recently bought kr475k worth of stock

OrganoClick AB (publ) (STO:ORGC) Just Reported Earnings, And Analysts Cut Their Target Price

Health Check: How Prudently Does OrganoClick (STO:ORGC) Use Debt?

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Third quarter 2021 earnings released: kr0.10 loss per share (vs kr0.072 loss in 3Q 2020)

Second quarter 2021 earnings released

Co-Founder recently bought kr210k worth of stock

First quarter 2021 earnings released: kr0.069 loss per share (vs kr0.063 loss in 1Q 2020)

Is OrganoClick (STO:ORGC) Weighed On By Its Debt Load?

Full year 2020 earnings released: kr0.26 loss per share (vs kr0.26 loss in FY 2019)